Recent studies found that dysregulation of SPARC is associated with a variety of obesity-related diseases, including type 2 diabetes and its complications related to obesity, kidney and liver disease, cardiovascular disease, and cancer (23). Here, SPARC is linked to obesity due to melanocortin 4 receptor deficiency.